Mefenaminsaeure en es it fr

Mefenaminsaeure Brand names, Mefenaminsaeure Analogs

Mefenaminsaeure Brand Names Mixture

  • No information avaliable

Mefenaminsaeure Chemical_Formula


Mefenaminsaeure RX_link

Mefenaminsaeure fda sheet

Mefenaminsaeure msds (material safety sheet)

Mefenaminsaeure MSDS

Mefenaminsaeure Synthesis Reference

No information avaliable

Mefenaminsaeure Molecular Weight

241.285 g/mol

Mefenaminsaeure Melting Point

230-231 oC

Mefenaminsaeure H2O Solubility

20 mg/L

Mefenaminsaeure State


Mefenaminsaeure LogP


Mefenaminsaeure Dosage Forms

Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)

Mefenaminsaeure Indication

For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.

Mefenaminsaeure Pharmacology

Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.

Mefenaminsaeure Absorption

Mefenamic acid is rapidly absorbed after oral administration.

Mefenaminsaeure side effects and Toxicity

Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.

Mefenaminsaeure Patient Information

Mefenaminsaeure Organisms Affected

Humans and other mammals